Mission:

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
elementor_library

The interventional pulmonology team’s mission is to provide the highest level of care for patients and their families with diseases of the airways, lungs, and the pleura.

Contents

Post Catagories

About Our Program

INTERVENTIONAL PULMONOLOGY AT HENRY FORD HOSPITAL

Advanced Diagnostics. Multimodality Therapy.  Research.  International Recognition.

Simple reasons why the Interventional Pulmonologists at Henry Ford Hospital are the leaders in the practice and advancement of Interventional Pulmonology in Michigan, in the United States and in the World.

Henry Ford Hospital’s Interventional Pulmonology Program has long led Michigan and the United States in the safe use and development of minimally invasive and other advanced technologies to diagnose and treat diseases of the lungs and airways. Our interventional pulmonologists specialize in all pulmonary diseases and complicated problems of the airways, both cancerous and benign (non-cancerous). Patients with lung cancer, cancer of the airways, pulmonary nodules, complex airways disease, complicated asthma, and other pulmonary conditions (see complete list below) will benefit from our program’s full scope of advanced services.  From the initial evaluation, to diagnosis of a complicated problem, to the treatment of early endobronchial disease to multimodality treatment for more complex conditions, we offer every diagnostic and therapeutic modality available to help patients with lung and airways diseases with the goal to provide each patient a personalized treatment plan best matched to the individual’s disease and current medical condition.  Henry Ford’s program is gaining international recognition for its success in blending sophisticated technology with research. 

Comprehensive, Personalized Care for Patients with Lung and Airways Diseases

 We know a diagnosis of lung and airways disease can be frightening to patients and families. The sensation of shortness of breath or the “suffocating” sensation that some people experience or the thought that you might have or are newly diagnosed with cancer can be not only uncomfortable, but very frightening.  The Henry Ford Interventional Pulmonology team provides comprehensive care to help every patient and family throughout the process of diagnosis and treatment. Our program components focus on combining quality and safety with the most advanced technologies to provide each patient the best possible treatment plan for recovery and quality of life.

 

WHAT IS INTERVENTIONAL PULMONOLOGY?

Henry Ford’s Interventional Pulmonology physicians offer a full scope of advanced diagnostic and therapeutic services, from the initial evaluation to endobronchial treatment of early disease to palliative management of complicated airways disease.  We are also involved in developing new techniques and technologies, allowing patients the benefit of the latest knowledge in the area of Interventional Pulmonology.  Our goal is to provide all possible techniques of Interventional Pulmonology, allowing us the ability to choose the best treatment options for each patient we see.

The History of Interventional Pulmonology at Henry Ford

The history of Interventional Pulmonology begins in 1897, when Gustav Killian a laryngologist at Freiburg University in Germany removed a foreign body from an airway. Professor Killian’s work in “bronchoscopy” demonstrated the flexibility of the trachea and the ability to work safely within the airway. The tool that Professor Killian used was the original rigid bronchoscope. A tool we still use today. Bronchoscopy was brought to the United States from Europe in 1898 by A. Coolidge at the Massachusetts General Hospital. It was in 1907 though that Chevalier Jackson, in Philadelphia Pennsylvania began his addition to the field of bronchoscopy by developing and improving the instruments for bronchoscopy and esophagoscopy. Chevalier Jackson is recognized as the ‘father of American bronchoesophagology’.

Bronchoscopy was introduced to Japan in 1907. It was here that Shigeto Ikeda developed the glasfiber illumination for the rigid bronchoscope in 1962. In the spring of 1964, Shigeto Ikeda approached Machida Endoscope Company to produce a prototype of what was to be the first flexible bronchoscope. This first prototype for a bronchofiberscope was made by Olympus Optical Company in 1966. In the fall of 1968, three new commercial bronchofiberscopes became available. Shigeto Ikeda spoke in September of 1968 at the National Institute of Health in the USA introducing the bronchofiberscope. In 1970, he offered the technique to the staff at Mayo Clinic.

Flexible bronchoscopy began at Henry Ford Hospital in 1971. Dr. Paul Kvale, a member of the Henry Ford Medical Group, was one of the national leaders in standardizing this new advanced technique.

Dr. Jean F. Dumon first presented his developmental work of Nd:YAG laser photoresection of airway tumors in 1980. Further new therapeutic uses of bronchoscopy quickly followed, including, laser resection of airway stenosis also in 1980 and photodynamic therapy in 1981. Following further development of therapeutic procedures, the rigid bronchoscope returned to become the definitive tool for airway therapeutic procedures. Stents, devices used to open blocked blood vessels in the heart or other organs of the body are also used in the airways. The first dedicated silicone stent for the trachea and bronchi was introduced by Dr. Dumon in 1990.

Again, Henry Ford quickly incorporated these new techniques into the management of our patients. Dr. Paul Kvale introduced laser bronchoscopy in 1982. He then received further training and incorporated the use of rigid bronchoscopy in 1983 for therapeutic management of malignant airways obstruction. Dr. Kvale was further involved in development of photodynamic therapy (PDT) for the management of endobronchial lung cancer. In 1993, the first Dumon silicone stent was placed in the airway of a patient at Henry Ford Hospital.

Dr. Michael Simoff trained with Dr. Kvale in bronchoscopy and interventional pulmonology during his Pulmonary and Critical Care Fellowship from 1993-1996.

Dr. Simoff purchased the first endobronchial ultrasound system at Henry Ford Hospital in 2000. Dr. Simoff was involved in the prototype evaluations and clinical testing of the endobronchial ultrasound guided transbronchial biopsy (EBUS-TBNA) bronchoscope, also referred to as the puncture scope. Dr. Simoff gave the talk that presented this new technology to the Community of Chest Physicians at the international meeting of the American College of Chest Physicians in 2003.

Over the past 10 years other advancements for the diagnosis and treatment of pulmonary disease that have been added include: Electrocautery and Argon Plasma Coagulation (2001), Cryotherapy (2002), Medical Thoracoscopy (2003), Autofluoresence (2004), Electromagnetic Navigation (superDimension Ltd) (2005), Microdebrider (2007), Confocal Microendoscopy (2006), and Endocytoscopy (2008). We have also been involved in the use of all airway stents and development of several other stents also over the past decade.

The Interventional Pulmonology Program at Henry Ford is also very involved in the advancement of interventional pulmonary education. We have offered the ‘Advanced Diagnostic Bronchoscopy’ course from 2004-2008. Because of its popularity it grew into the ‘Advanced Diagnostic Bronchoscopy and Thoracic Ultrasound’ Course, which began in 2009. The Interventional Pulmonology program at Henry Ford also offers one of the few one year advanced fellowships in Interventional Pulmonology offered throughout the United States.

The History of interventional pulmonology began over a century ago. The Interventional Pulmonology program at Henry Ford plans on continuing to contribute to the expansion and identity of this new field into the future.

Advanced Diagnostic Techniques and Technologies

Henry Ford’s Interventional Pulmonology team is among a few in the nation developing and using the newest diagnostic technologies.  On many occasions it is necessary to use multiple techniques to make the diagnosis for a patient.  As our program offers all techniques we can use the best procedure or combination of procedures for every patient.  In addition to routine diagnostic bronchoscopy we offer:

  • Autofluoresence Bronchoscopy
  • Endobronchial Ultrasound Guided Transbronchial Needle Aspiration
  • Endobronchial Ultrasound for Peripheral Lesions
  • Endobronchial Ultrasound to assess Central airways
  • Electromagnetic Guidance Techniques
  • Transbronchial Needle Aspiration Biopsy
  • Rigid and Flexible Biopsy Techniques
  • Robotic Bronchoscopy
  • CT Guided Bronchoscopic procedures

 

Interventional Pulmonology: Advanced Therapeutic Techniques

  • Rigid and Flexible Bronchoscopy
    • Laser Therapy (neodymium:YAG , KTP, CO2)
    • Cryotherapy
    • Electrocautery
    • Argon Plasma Coagulation
    • Microdebriedment
    • Balloon Dilatation
    • Brachytherapy
    • Fibrin Glue Application
    • Photodynamic Therapy
    • Bronchoscopic Lung Volume Reduction for COPD
    • Endobronchial Valve Placement
    • Bronchial Thermoplasty
    • Airway Stenting
      • Metallic Stents
      • Silastic Stents
      • Hybrid Stents
      • Montgomery T-tubes
  • Metallic Stent Removal
  • Medical Thoracoscopy
    • Diagnostic
    • Therapeutic
  • Indwelling Pleural Catheter Placement and Management
  • Whole Lung Lavage (Single and Bilateral)

Multimodality Therapy For Complex Airways Diseases

We offer every diagnostic and therapeutic modality, because every problem like every patient is different and we want to ensure that we have the capacity to help the greatest number of patients as is possible.  Most patients will require some combination of diagnostic and/or therapeutic procedures to diagnose or treat their condition.  Our goal is to offer this complete approach to every patient when they present to us.

We evaluate and treat both malignant and non-malignant pulmonary diseases with Interventional Pulmonary techniques.  We have an aggressive program for the management of endobronchial tumor growth (tumor growing in the airway) as well as extrinsic airway compression (tumor or some other structure squeezing the airways from outside of them).  By treating patients with compromised airways before other therapies begin, we can improve a patient’s breathing capacity and therefore often the ability to tolerate their treatment. We have also created a comprehensive program for the management of tracheal stenosis, tracheobronchomalacia, tracheoesophageal fistulas, airway papillomas, and post surgical bronchopleural fistulas. The Interventional Pulmonology team also performs single and bilateral whole lung lavage for pulmonary alveolar proteinosis.